Indiana 2022 Regular Session

Indiana Senate Bill SB0175

Introduced
1/10/22  

Caption

Medical cannabis.

Impact

The bill has significant implications for state laws relating to drug use, health care, and agriculture. By formalizing a medical cannabis program, the legislation permits legal access to cannabis for therapeutic purposes and sets up a tax framework to collect revenue from medical cannabis sales. Medical cannabis organizations will have to adhere to strict licensing and operation standards, including inventory tracking and packaging in child-resistant containers. This structured approach aims to enhance product safety and ensure that only qualified individuals can access medical cannabis.

Summary

Senate Bill 175, concerning medical cannabis, establishes a comprehensive framework for the cultivation, processing, testing, transportation, and dispensing of medical cannabis within Indiana. It defines 'medical cannabis' while explicitly excluding smokable versions and those mixed with food products, and permits usage only for individuals diagnosed with qualifying medical conditions as determined by licensed physicians. Furthermore, the bill establishes the Indiana Cannabis Commission, which will oversee the medical cannabis program and ensure compliance with regulations. The bill aims to improve access to medical cannabis for eligible patients throughout the state while implementing stringent control measures to prevent unauthorized distribution.

Contention

Despite its potential benefits, SB 175 has sparked considerable debate. Supporters argue that providing regulated access to medical cannabis can lead to improved health outcomes for patients suffering from serious medical conditions. Conversely, opponents express concerns over the bill's provisions, fearing it may inadvertently promote wider cannabis use beyond medical applications. There is also apprehension regarding the adequacy of safeguards to prevent misuse and the potential unintended impacts on community health and safety. The delineation of responsibilities among medical cannabis organizations, patients, and caregivers has been a focal point of discussion among legislators and stakeholders.

Companion Bills

No companion bills found.

Previously Filed As

IN SB0341

Medical cannabis.

IN HB1635

Medical cannabis.

IN SB0113

Cannabis regulation.

IN SB0286

Cannabis regulation.

IN HB1332

Cannabis.

IN HB1630

Cannabis legalization.

IN AB1332

Medicinal cannabis: shipments.

IN SB1064

Relating To Medical Cannabis.

IN SB1064

Relating To Medical Cannabis.

IN SF2372

Medical cannabis and cannabis provisions modification

Similar Bills

US HR198

Providing for the expenses of certain committees of the House of Representatives in the One Hundred Nineteenth Congress.

MN HC1

A house concurrent resolution relating to the regent nomination joint committee.

IL HR0020

HOUSE RULES-AMEND

CA AB1350

Employment Development Department: policies and practices.

NM HJM2

Combine Standing & Interim Committees

MN HC2

A House concurrent resolution relating to the adjournment of the House of Representatives and Senate until 2026.

CA SB829

California Institute for Scientific Research: CalRx Initiative: vaccines.

AR HB1573

To Reorganize The Standing Committees And The Subject Matter Interim Committees Of The House Of Representatives.